Bavarian Nordic signs first smallpox vaccine deal in the EU
This article was originally published in Scrip
Bavarian Nordic has signed its first contract with the military of an EU country for the delivery of a small order of its smallpox vaccine, Imvamune. The Danish vaccine firm would not disclose the identity of the buyer (who has bought the vaccine for preparedness stockpiles) or the value of the deal, adding that the delivery will occur this year.
You may also be interested in...
The US Food and Drug Administration recently signalled its desire to work more closely with other drug regulators in assessing the quality of pharmaceutical manufacturing facilities around the world.
It seems as if the US FDA is softening its stance on assessing the quality of pharmaceutical manufacturing facilities around the world in future, with an apparent desire to work more closely with other drug regulators. However, incorporating the regulators from countries such as India, China and Japan into a global inspectorate still looks problematical.
Large pharmaceutical companies and Médecins sans Frontières may not often see eye-to-eye over access to medicines in poor countries. But it seems as if industry and the humanitarian body, a prominent critic, do agree that competition works in improving access to vaccines, even though they don't agree about the mechanisms of price setting.